Cyclosporin for treatment of refractory multisystemic inflammatory syndrome in a child.
Cardiol Young
; : 1-3, 2022 Sep 02.
Article
in English
| MEDLINE | ID: covidwho-20235782
ABSTRACT
Multisystemic inflammatory syndrome in children is an inflammatory condition with multiorgan dysfunction that manifest late in the course of Severe acute respiratory syndrome coronavirus 2 infection. We present a 12-year-old boy with a history of fever, vomiting, diarrhoea, and abdominal pain. He developed shock with ventricular dysfunction and pericardial effusion. He was diagnosed with multisystemic inflammatory syndrome in children and treatment with intravenous immunoglobulins, corticosteroids, and tocilizumab proved to be ineffective. Eventually, the patient responded to cyclosporin-A treatment. Multisystemic inflammatory syndrome in children has been treated with immunoglobulins and glucocorticoids and in refractory cases biologics and cyclosporin-A have been used. Intravenous and oral cyclosporin-A seems to be a safe and effective alternative treatment for refractory multisystemic inflammatory syndrome in children patients.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
Cardiol Young
Journal subject:
Vascular Diseases
/
Cardiology
/
Pediatrics
Year:
2022
Document Type:
Article
Affiliation country:
S1047951122002748
Similar
MEDLINE
...
LILACS
LIS